Korean J Clin Microbiol.  2011 Dec;14(4):153-157. 10.5145/KJCM.2011.14.4.153.

Three Adult Cases of Elizabethkingia meningoseptica Infection in a Korean Hospital

• Kim J
• Park YJ
• Shin S
• Kim Y
• Park SH

• KMID: 1476038
• DOI: http://doi.org/10.5145/KJCM.2011.14.4.153

Abstract

Elizabethkingia meningoseptica (Chryseobacterium meningoseptica) is a ubiquitous Gram-negative bacillus in the natural and hospital environments. This microorganism causes neonatal meningitis but rarely causes infections in adults, with most adult cases occurring in severely immunocompromised patients. Since E. meningoseptica is inherently resistant to the usual empiric therapy aimed at Gram-negative bacilli and MIC breakpoints for resistance and susceptibility of E. meningoseptica have not been established by the Clinical and Laboratory Standards Institute, it is very difficult to select effective antibiotics for the treatment of E. meningoseptica infection. We report here three cases of E. meningoseptica isolates (two from blood and one from CSF) from adult patients admitted to Seoul St. Mary's hospital over a 3-year period. To the best of our knowledge, this is the first report of adult meningitis due to E. meningoseptica in Korea.

Keyword

Elizabethkingia meningoseptica; Blood; CSF

MeSH Terms

Adult
Anti-Bacterial Agents
Bacillus
Humans
Immunocompromised Host
Korea
Meningitis
Anti-Bacterial Agents

Reference

1. Bloch KC, Nadarajah R, Jacobs R. Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review. Medicine (Baltimore). 1997; 76:30–41.

2. Kim KK, Kim MK, Lim JH, Park HY, Lee ST. Transfer of Chryseobacterium meningosepticum and Chryseobacterium miricola to Elizabethkingia gen. nov. as Elizabethkingia meningoseptica comb. nov. and Elizabethkingia miricola comb. nov. Int J Syst Evol Microbiol. 2005; 55:1287–93.

3. Lin YT, Chiu CH, Chan YJ, Lin ML, Yu KW, Wang FD, et al. Clinical and microbiological analysis of Elizabethkingia meningoseptica bacteremia in adult patients in Taiwan. Scand J Infect Dis. 2009; 41:628–34.

4. Murray PB, Baron EJ, et al. eds. Manual of Clinical Microbiology. 9th ed.American Society for Microbiology;2006. p. 791–93.

5. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing 19th informational supplement. CLSI document M100, S17. Wayne, PA: Standards Institute;2009.

6. Yum JH, Lee EY, Hur SH, Jeong SH, Lee H, Yong D, et al. Genetic diversity of chromosomal metallo-beta-lactamase genes in clinical isolates of Elizabethkingia meningoseptica from Korea. J Microbiol. 2010; 48:358–64.

7. Lee NY, Kim MS, Kim MN, Kim MJ, Kim S, Kim SI, et al. Annual report on external quality assessment in clinical microbiology laboratory in Korea (2008). J Lab Med Qual Assur. 2009; 31:13–27.

8. Kirby JT, Sader HS, Walsh TR, Jones RN. Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001). J Clin Microbiol. 2004; 42:445–8.